153 related articles for article (PubMed ID: 32112669)
1. Simultaneous confidence interval for assessing non-inferiority with assay sensitivity in a three-arm trial with binary endpoints.
Tang N; Yu B
Pharm Stat; 2020 Sep; 19(5):518-531. PubMed ID: 32112669
[TBL] [Abstract][Full Text] [Related]
2. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
Tang NS; Yu B; Tang ML
BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
[TBL] [Abstract][Full Text] [Related]
3. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
Sankoh AJ
Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
[TBL] [Abstract][Full Text] [Related]
4. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
Pigeot I; Schäfer J; Röhmel J; Hauschke D
Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
[TBL] [Abstract][Full Text] [Related]
5. Multiple-arm superiority and non-inferiority designs with various endpoints.
Chang M
Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
[TBL] [Abstract][Full Text] [Related]
6. Confidence interval construction for the difference between two correlated proportions with missing observations.
Tang NS; Li HQ; Tang ML; Li J
J Biopharm Stat; 2016; 26(2):323-38. PubMed ID: 25632882
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials.
Scharpenberg M; Brannath W
Stat Methods Med Res; 2023 Sep; 32(9):1784-1798. PubMed ID: 37503578
[TBL] [Abstract][Full Text] [Related]
8. Design and analysis of non-inferiority mortality trials in oncology.
Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
[TBL] [Abstract][Full Text] [Related]
9. Bayesian approach for assessing non-inferiority in a three-arm trial with pre-specified margin.
Ghosh S; Ghosh S; Tiwari RC
Stat Med; 2016 Feb; 35(5):695-708. PubMed ID: 26434554
[TBL] [Abstract][Full Text] [Related]
10. Testing superiority and non-inferiority hypotheses in active controlled clinical trials.
Tsong Y; Zhang JJ
Biom J; 2005 Feb; 47(1):62-74; discussion 99-107. PubMed ID: 16395997
[TBL] [Abstract][Full Text] [Related]
11. Testing non-inferiority and superiority for two endpoints for several treatments with a control.
Lawrence J
Pharm Stat; 2011; 10(4):318-24. PubMed ID: 20949636
[TBL] [Abstract][Full Text] [Related]
12. Bayesian approach for assessing noninferiority in a three-arm trial with binary endpoint.
Ghosh S; Tiwari RC; Ghosh S
Pharm Stat; 2018 Jul; 17(4):342-357. PubMed ID: 29473291
[TBL] [Abstract][Full Text] [Related]
13. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
Hida E; Tango T
J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
[TBL] [Abstract][Full Text] [Related]
14. Planning and analysis of three-arm non-inferiority trials with binary endpoints.
Kieser M; Friede T
Stat Med; 2007 Jan; 26(2):253-73. PubMed ID: 16685703
[TBL] [Abstract][Full Text] [Related]
15. Some fundamental issues with non-inferiority testing in active controlled trials.
James Hung HM; Wang SJ; Tsong Y; Lawrence J; O'Neil RT
Stat Med; 2003 Jan; 22(2):213-25. PubMed ID: 12520558
[TBL] [Abstract][Full Text] [Related]
16. Design and analysis of a 3-arm noninferiority trial with a prespecified margin for the hazard ratio.
Hida E; Tango T
Pharm Stat; 2018 Sep; 17(5):489-503. PubMed ID: 29984524
[TBL] [Abstract][Full Text] [Related]
17. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
Hida E; Tango T
Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
[TBL] [Abstract][Full Text] [Related]
18. Confidence intervals construction for difference of two means with incomplete correlated data.
Li HQ; Tang NS; Yi JY
BMC Med Res Methodol; 2016 Mar; 16():31. PubMed ID: 26969507
[TBL] [Abstract][Full Text] [Related]
19. Bayesian sample size determination in a three-arm non-inferiority trial with binary endpoints.
Tang N; Yu B
J Biopharm Stat; 2022 Sep; 32(5):768-788. PubMed ID: 35213275
[TBL] [Abstract][Full Text] [Related]
20. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
Hirotsu C
Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
